The tragic case of Harry Miller highlights the potential risks associated with montelukast use . FDA and MHRA Warnings: Regulatory agenci...
The tragic case of Harry Miller highlights the potential risks associated with montelukast use.
FDA and MHRA Warnings: Regulatory agencies have issued warnings about the drug's neuropsychiatric adverse effects.
Patient advocacy groups are calling for stricter regulations on montelukast.
Despite global concerns, montelukast is widely and often inappropriately prescribed in India.
Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma
COMMENTS